UNSPSC 41116030: Anti B serum, monoclonal

Shelf Life: 36 Months Product: Anti-B Colour: Yellow Dye Used: Tartrazine The reagents will cause direct agglutination (clumping) of test red cells that carry the corresponding ABO antigen. No agglutination generally indicates absence of the corresponding ABO antigen. Lorne Monoclonal IgM ABO blood grouping reagents contain murine monoclonal antibodies diluted in a phosphate buffer containing sodium chloride, EDTA and bovine albumin. Each reagent is supplied at optimal dilution for use with slide, tube, gel card & microplate techniques. Reagent vials should be stored at 2 - 8oC on receipt.

Prolonged storage at temperatures outside this range may result in accelerated loss of reagent reactivity.

UNSPSC 41116030 Anti B serum, monoclonal (Commodity) shows sparse recent state and local procurement activity. The code encompasses monoclonal antibody serums used in immunology and diagnostic testing; state and local buyers source these materials for forensic laboratories, clinical diagnostics, hospital systems, and public health agencies supporting specimen analysis and patient care. The recent opportunities block identifies one direct solicitation: Williamson County, Texas issued IFB 26IFB63 on July 15, 2026, for EMS Medical and Pharmaceutical Items, responses due August 4, 2026—a broad-scope notice that does not detail whether monoclonal serums are part of the line items. The remaining opportunities in the block—flow cytometry analyzers, offender drug testing services, water lab testing, forensic toxicology, proficiency testing samples, and laboratory consumables—are tangentially related or unrelated to anti-B serum procurement.

Geographic activity and issuing-body concentration are not clearly supported by the source. Williamson County, Texas appears as the only state or local jurisdiction explicitly soliciting under or near this code in the recent opportunities. University of Wisconsin-Madison and the District of Columbia Department of Finance and Services both posted related immunology and laboratory procurement notices, but these are academic and federal entities respectively, outside the state and local government scope. Without additional recent opportunities showing sustained activity across multiple counties, cities, school districts, or transit authorities, the code shows minimal recent state and local procurement velocity. Firms pursuing this code should monitor academic medical centers, hospital districts, and forensic laboratories in Texas and the broader South and West, but the current opportunity pipeline is thin and does not support confident market assessment.